Following her recent examination of the limitations of adverse event data in medicinal cannabis, Dr Teresa Nicoletti argues the Therapeutic Goods Administration’s (TGA) latest discussion paper may point to a broader regulatory recalibration of high-THC products and inhaled cannabis.
The TGA recently submitted a “discussion paper” to the Advisory Committee on Medicines Scheduling (ACMS) summarising the findings from the consultation on the safety and regulatory oversight of unapproved medicinal cannabis products and including the following attachments:
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and
international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
It’s a difficult path to navigate as the TGA is responsible only for safe medicines however if the TGA makes it much more restrictive to obtain THC flower; there is little doubt the black market will be the place where patients go to get unsafe, unregulated and unapproved medicine. The current process at least ensures quality product through testing and patients needing to talk to a medical professional. The black market removes all these safe guards.